000 01775 a2200457 4500
005 20250516133908.0
264 0 _c20130730
008 201307s 0 0 fre d
022 _a0151-9638
024 7 _a10.1016/j.annder.2012.11.012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHüe, S
245 0 0 _a[Systemic sclerosis autoantibodies: what dermatologists must know].
_h[electronic resource]
260 _bAnnales de dermatologie et de venereologie
_cFeb 2013
300 _a143-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntibodies, Antinuclear
_xblood
650 0 4 _aAutoantigens
_ximmunology
650 0 4 _aCell Nucleolus
_ximmunology
650 0 4 _aCentromere
_ximmunology
650 0 4 _aChromosomal Proteins, Non-Histone
_ximmunology
650 0 4 _aDNA Topoisomerases, Type I
_ximmunology
650 0 4 _aDNA-Directed RNA Polymerases
_ximmunology
650 0 4 _aEndothelium, Vascular
_xpathology
650 0 4 _aExoribonucleases
_ximmunology
650 0 4 _aExosome Multienzyme Ribonuclease Complex
_ximmunology
650 0 4 _aFibroblasts
_xpathology
650 0 4 _aFibrosis
650 0 4 _aFluorescent Antibody Technique, Indirect
650 0 4 _aHumans
650 0 4 _aLymphocyte Subsets
_ximmunology
650 0 4 _aOxidative Stress
650 0 4 _aPol1 Transcription Initiation Complex Proteins
_ximmunology
650 0 4 _aRaynaud Disease
_xetiology
650 0 4 _aRibonucleoprotein, U1 Small Nuclear
_ximmunology
650 0 4 _aScleroderma, Systemic
_xcomplications
700 1 _aIngen-Housz-Oro, S
700 1 _aCosnes, A
773 0 _tAnnales de dermatologie et de venereologie
_gvol. 140
_gno. 2
_gp. 143-9
856 4 0 _uhttps://doi.org/10.1016/j.annder.2012.11.012
_zAvailable from publisher's website
999 _c22490905
_d22490905